SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-24-030858
Filing Date
2024-08-09
Accepted
2024-08-09 06:15:39
Documents
1
Period of Report
2024-07-12

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1501
  Complete submission text file 0001493152-24-030858.txt   3038
Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011
Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165
Qualigen Therapeutics, Inc. (Issuer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 5857 OWENS AVENUE SUITE 300 CARLSBAD CA 92008
Business Address
BECHER CAMPBELL (Reporting) CIK: 0002032433 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37428 | Film No.: 241190322